Cite
HARVARD Citation
Lim, L. et al. (2017). Five‐year efficacy and safety of tenofovir‐based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy. Liver international. pp. 827-835. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lim, L. et al. (2017). Five‐year efficacy and safety of tenofovir‐based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy. Liver international. pp. 827-835. [Online].